Hainan Visum Pharmaceutical Co Ltd announced that it has received $15,000,000 in a round of funding led by Zhejiang Hisoar Pharmaceutical Co., Ltd. on June 29, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.09 CNY | +4.28% | +3.22% | -15.30% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.30% | 1.34B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- 002099 Stock
- News Zhejiang Hisoar Pharmaceutical Co., Ltd.
- Hainan Visum Pharmaceutical Co Ltd announced that it has received $15 million in funding from Zhejiang Hisoar Pharmaceutical Co., Ltd.